Principal Financial Group’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-38,065
Closed -$107K 2361
2024
Q2
$107K Buy
38,065
+2,977
+8% +$7.99K ﹤0.01% 2214
2024
Q1
$99.7K Buy
+35,088
New +$119K ﹤0.01% 2278
2023
Q4
Sell
-10,101
Closed -$32.1K 2446
2023
Q3
$32.1K Buy
+10,101
New +$32.1K ﹤0.01% 2380
2023
Q2
Sell
-30,746
Closed -$65.5K 2469
2023
Q1
$65.5K Sell
30,746
-434,661
-93% -$1.07M ﹤0.01% 2353
2022
Q4
$1.25M Buy
465,407
+10,674
+2% +$31.1K ﹤0.01% 1830
2022
Q3
$1.47M Buy
454,733
+10,719
+2% +$48.4K ﹤0.01% 1774
2022
Q2
$2.17M Sell
444,014
-37,995
-8% -$234K ﹤0.01% 1785
2022
Q1
$3.67M Sell
482,009
-18,068
-4% -$140K ﹤0.01% 1752
2021
Q4
$4.62M Buy
500,077
+2,630
+0.5% +$27.9K ﹤0.01% 1691
2021
Q3
$7.08M Buy
497,447
+79,930
+19% +$1.24M ﹤0.01% 1557
2021
Q2
$6.94M Buy
+417,517
New +$7.78M ﹤0.01% 1607

Other funds holding ORGO

Principal Financial Group's ORGO Position: Q3 2024 in Review

Principal Financial Group sold out of Organogenesis Holdings (ORGO) in Q3 2024, closing a stake of 38,065 shares — an estimated $107K sold.

Principal Financial Group first reported a position in ORGO in Q2 2021 and held it in 11 quarters. The position peaked at $7.08M in Q3 2021. 112 funds tracked by Wall St. Rank hold ORGO as of Q3 2024.

  • Principal Financial Group reported no remaining Organogenesis Holdings position as of Q3 2024 after selling out during the quarter.
  • Principal Financial Group sold 38,065 Organogenesis Holdings shares in Q3 2024, an estimated $107K.
  • Principal Financial Group first reported a position in Organogenesis Holdings in Q2 2021 and held it in 11 quarters.
  • Principal Financial Group's Organogenesis Holdings position peaked at $7.08M in Q3 2021.
  • 112 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2024.

Based on Principal Financial Group's 13F filing for Q3 2024, filed 31 Oct 2024.